Evidence map›Paper›PMID 38721374›Full record

ArticleACS catalysis2024

Asymmetric Synthesis of Chiral 2-Cyclohexenones with Quaternary Stereocenters via Ene-Reductase Catalyzed Desymmetrization of 2,5-Cyclohexadienones.

Michael Friess, Amit Singh Sahrawat, Bianca Kerschbaumer, Silvia Wallner, Ana Torvisco, Roland Fischer, Karl Gruber, Peter Macheroux, Rolf Breinbauer

Abstract read
In one paragraph

Article in ACS catalysis, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Michael FriessInstitute of Organic Chemistry, Graz University of Technology, Stremayrgasse 9, 8010 Graz, Austria.
Amit Singh SahrawatInstitute of Molecular Biosciences, University of Graz, Humboldtstraße 50, 8010 Graz, Austria.ORCID https://orcid.org/0000-0002-8324-6545
Bianca KerschbaumerInstitute of Biochemistry, Graz University of Technology, Petersgasse 10-12, 8010 Graz, Austria.
Silvia WallnerInstitute of Biochemistry, Graz University of Technology, Petersgasse 10-12, 8010 Graz, Austria.
Ana TorviscoInstitute of Inorganic Chemistry, Graz University of Technology, Stremayrgasse 9, 8010 Graz, Austria.ORCID https://orcid.org/0000-0002-6203-7330
Roland FischerInstitute of Inorganic Chemistry, Graz University of Technology, Stremayrgasse 9, 8010 Graz, Austria.ORCID https://orcid.org/0000-0001-9523-5010
Karl GruberInstitute of Molecular Biosciences, University of Graz, Humboldtstraße 50, 8010 Graz, Austria.ORCID https://orcid.org/0000-0002-3485-9740
Peter MacherouxInstitute of Biochemistry, Graz University of Technology, Petersgasse 10-12, 8010 Graz, Austria.
Rolf BreinbauerInstitute of Organic Chemistry, Graz University of Technology, Stremayrgasse 9, 8010 Graz, Austria.ORCID https://orcid.org/0000-0001-6009-7359

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stereoselective synthesis of quaternary stereocenters represents a significant challenge in organic chemistry. Herein, we describe the use of ene-reductases OPR3 and YqjM for the efficient asymmetric synthesis of chiral 4,4-disubstituted 2-cyclohexenones via desymmetrizing hydrogenation of prochiral 4,4-disubstituted 2,5-cyclohexadienones. This transformation breaks the symmetry of the cyclohexadienone substrates, generating valuable quaternary stereocenters with high enantioselectivities (ee, up to >99%). The mechanistic causes for the observed high enantioselectivities were investigated both experimentally (stopped-flow kinetics) as well as theoretically (quantum mechanics/molecular mechanics calculations). The synthetic potential of the resulting chiral enones was demonstrated in several diversification reactions in which the stereochemical integrity of the quaternary stereocenter could be preserved.

Identifiers

PMID38721374
PMCPMC11075021

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.